CDKN2B-AS1 and type 2 diabetes mellitus: Concerning thepotential role of ANRIL in CAD and T2DM, and itsexpression in inflammatory (9, 10) cells provoked usto know whether its expression in PBMCs is associatedwith CAD progression in T2DM patients.